pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Beam Therapeutics Inc
Search

Beam Therapeutics Inc

Closed

Sector Healthcare

23.33 -2.55

Buy

Price update 6 wrz 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

23.2

Max

23.42

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+103.78 upside

News Sentiment

By Acuity

43%

57%

94 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 26.81 Support & Resistance

Beam Therapeutics Inc Chart

Related News

31 paź 2023, 10:44 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

DJ

Read

24 lis 2023, 12:00 UTC

Top News

Gene Editing Will Change Medicine -- and Maybe Health Investing Too -- Heard on the Street -- WSJ

DJ

Read

31 paź 2023, 10:29 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

DJ

Read

Peer Comparison

Price change

Beam Therapeutics Inc Forecast

Price Target

By TipRanks

103.78% upside

12 Months Forecast

Average 47.5 USD  103.78%

High 80 USD

Low 27 USD

Based on 9 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

5

Buy

4

Hold

0

Sell

Based on 9 analysts giving stock ratings to Beam Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 26.81Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

94 / 365 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%